Randomized Clinical Trial, Conventional Treatment-controlled, Studying the Efficacy of Plasma Rich in Growth Factor (PRGF®) in Alveolar Ridge Preservation After Simple Exodontia in the Anterior Region of Maxilla.

Phase 3 Completed 46 enrolled Fundación Eduardo Anitua

RandomizedParallel-groupSingle-blindTreatment

Summary

This RCT aims to study the efficacy and safety of PRGF-Endoret in alveolar ridge preservation in the aesthetic zone. The control group is the spontaneous healing occuring after the suturing of the alveolus. The primary endpoint is the bone regeneration measured in biopsies obtained from the regenerated alveolar bone.

Timeline

Start: 2019-11-07
Primary completion: 2025-01-29
Completion: 2025-01-29

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	PRGF-Endoret	Protein / enzyme biologic	—	—

Indications

No indication recorded.